![Seres Therapeutics, Inc. logo](/logos/MCRB.webp)
Seres Therapeutics, Inc.
NASDAQ:MCRB
Overview | Financials
Company Name | Seres Therapeutics, Inc. |
Symbol | MCRB |
Currency | USD |
Price | 0.954 |
Market Cap | 145,357,190 |
Dividend Yield | 0% |
52-week-range | 0.54 - 3.275 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Eric D. Shaff M.B.A. |
Website | https://www.serestherapeutics.com |
An error occurred while fetching data.
About Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD